Nan-chang C. Chiu
Expertise in
10
conditions

Nan-chang C. Chiu

No. 92, Sec. 2, Zhongshan N. Rd, 
TPQ, TW 
Expertise in
10
conditions
No. 92, Sec. 2, Zhongshan N. Rd, 
TPQ, TW 
OverviewLocationsClinical Research

Overview

Nan-chang Chiu practices in Taiwan. Chiu is highly rated in 10 conditions, according to our data. Their top areas of expertise are Osteomyelitis in Children, Respiratory Syncytial Virus (RSV) Infection, Subependymal Nodular Heterotopia, and Strep Throat.

Their clinical research consists of co-authoring 161 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

No. 92, Sec. 2, Zhongshan N. Rd, TPQ 10449, Taiwan
Other Locations
No. 92, Zhongshan N Rd, Zhongshan District, TPQ 10449, Taiwan
92, Chung Shan North Road, TPQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II, Prospective, Double-blinded, Multi-Center Study to Evaluate the Safety, Tolerability, and Immunogenicity of the SARS CoV 2 Vaccine Candidate MVC COV1901 in Adolescents
A Phase II, Prospective, Double-blinded, Multi-Center Study to Evaluate the Safety, Tolerability, and Immunogenicity of the SARS CoV 2 Vaccine Candidate MVC COV1901 in Adolescents
Enrollment Status: Completed
Publish Date: April 20, 2022
Intervention Type: Biological
Study Phase: Phase 2
A Phase III, Observer-blind, Randomized, Multi-country Study to Assess the Reactogenicity and Safety of the Porcine Circovirus (PCV) Free Liquid Formulation of GSK's Oral Live Attenuated Human Rotavirus (HRV) Vaccine as Compared to the Lyophilized Formulation of the GSK's HRV Vaccine, When Administered as a 2-dose Vaccination in Infants Starting at Age 6-12 Weeks
A Phase III, Observer-blind, Randomized, Multi-country Study to Assess the Reactogenicity and Safety of the Porcine Circovirus (PCV) Free Liquid Formulation of GSK's Oral Live Attenuated Human Rotavirus (HRV) Vaccine as Compared to the Lyophilized Formulation of the GSK's HRV Vaccine, When Administered as a 2-dose Vaccination in Infants Starting at Age 6-12 Weeks
Enrollment Status: Completed
Publish Date: March 10, 2022
Intervention Type: Biological
Study Phase: Phase 3
View 1 Less Clinical Trial

161 Total Publications

Efficacy of nirsevimab for the prevention of RSV disease in infants: A systematic review, meta-analysis of randomized controlled trials, and global perspectives on recommendations and unmet needs.
Efficacy of nirsevimab for the prevention of RSV disease in infants: A systematic review, meta-analysis of randomized controlled trials, and global perspectives on recommendations and unmet needs.
Journal: Pediatrics and neonatology
Published: May 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chiu's expertise for a condition
ConditionClose
      View All 10 Advanced Conditions
      View All 64 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile